Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition by Arehart Eric, Stitham Jeremiah, Asselbergs Folkert W, Douville Karen, MacKenzie Todd, Fetalvero Kristina M, Gleim Scott, Kasza Zsolt, Rao Yamini, Martel Laurie, Segel Sharon, Robb John, Kaplan Aaron, Simons Michael, Powell Richard J, Moore Jason H, Rimm Eric B, Martin Kathleen A, Hwa John in Circulation research (2008).

[PMID: 18323528] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.